COVID -19 disease.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: People with a diagnosis of COVID -19 and hospitalization in general wards Having the necessary ability to conduct studies Involvement of lung tissue according to CT scan In both sexes men and women in the age group of 18 to 70 years who have recently been admitted Have signed the informed consent form to participate in the study They do not participate in another clinical trial at the same time
Exclusion criteria
Exclusion criteria: History of previous illness Pregnancy and lactation Serious heart and lung disease Blood pressure above 160 mm Hg history of allergic symptoms Consumption of herbal perfumes as well as synthetic sprays effective on airway obstruction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Arterial oxygen saturation. Timepoint: Every 24 hours. Method of measurement: With pulse oximetry device.;Respiratory rate. Timepoint: every 24 hours. Method of measurement: By monitoring device.;Blood pressure. Timepoint: every 24 hours. Method of measurement: By monitoring device.;Heart rate. Timepoint: every 24 hours. Method of measurement: By monitoring device.;White blood cells. Timepoint: every 24 hours. Method of measurement: Perform a complete blood count test.;Fever. Timepoint: every 24 hours. Method of measurement: By thermometer device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ghoum University of Medical Sciences